Sindrome de anticuerpos antifosfolipidos pdf 2011

Definition of human autoimmunity-autoantibodies versus autoimmune disease. Autoimmun Rev. Pers, C. Rojas-Villarraga, P. Youinou, J. Best Pract Res Clin Rheumatol. Fonollosa Pla, M. Labrador Horrillo, M. Vilardell Tarres. Med Lab. Robles, M. Serv Enfermedades Sist Barcelona. Avery, M. Austen, J. Anti-nuclear antibodies in daily clinical practice: Prevalence in primary, secondary, and tertiary care. J Immunol Res.

Cabiedes, C. Reumatol Clin. Mierendorf, R. Hosp Med Clin. Damoiseaux, C. Carballo, W. Francescantonio, et al. Autoimmun Highlights. Kavanaugh, R. Tomar, J. Reveille, D. Solomon, H. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med. CO;2 Medline. Satoh, E. Chan, L. Ho, K. Rose, C. Parks, R. Cohn, et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States.

Arthritis Rheum. Petri, A. Orbai, G. Gordon, J. Merrill, P. Fortin, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Tozzoli, N. Bizzaro, E. Tonutti, D. Villalta, D.

Bassetti, F. Manoni, et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol. Severiche Maury, M. Escobar, L. Naranjo, A. Vahos, G. Rev Colomb Reumatol. Derksen, E. Bast, T. Strooisma, J. A comparison between the Farr radioimmunoassay and a new automated fluorescence immunoassay for the detection of antibodies against double stranded DNA in serum. Ann Rheum Dis. Riboldi, M. Gerosa, G.

Moroni, A. Radice, F. Allegri, A. Sinico, et al. Anti-DNA antibodies: A diagnostic and prognostic tool for systemic lupus erythematosus?. Hernando, C. Guevara, J.

Alejandro Navajo, W. Papisch, et al. Clinical evaluation of a new automated anti-dsDNA fluorescent immunoassay. Clin Chem Lab Med. Wasmuth, B. Grun, B. Terjung, A. Homrighausen, U. ROC analysis comparison of three assays for the detection of antibodies against double-stranded DNA in serum for the diagnosis of systemic lupus erythematosus. Clin Chem. Haugbro, J. Nossent, T. Winkler, Y. Figenschau, O. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: The role of analytical diversity.

Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med. Anti-ribosomal P antibodies and lupus nephritis.

Clin Exp Nephrol. Toubi, Y. Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Hanly, M. Urowitz, L. Su, S. Bae, C. Gordon, A. Clarke, et al. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus. Hemos derivado su inquietud a la Bqca. De antemano muchas gracias. Estimada Soledad Gracias por contactarse con Grupo Gamma. Temas Salud general. Marisa Azcuenaga dijo:. Para responder, debes estar logueado.

Grupo Gamma dijo:. Paula Aranda dijo:. Gloria dijo:. Kuratsune, E. Suehisa, Y. Futsukaichi, H. Yamanishi, T. Machii, et al. Association between the prevalence of antibodies to beta 2 -glycoprotein I, trothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications.

Clin Chem, 47 , pp. Reverter, D. Font, J. Monteagudo, G. Escolar, M. Ingelmo, et al. Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein S.

Arterioscler Thromb Vasc Biol, 16 , pp. Font, M. Khamashta, K. Ichikawa, R. Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes. Arthritis Rheum, 41 , pp. CO;2-U Medline. Dobado-Barrios, C. Lopez-Pedrera, F. Velasco, M. Aguirre, A. Torres, M. Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome. Thromb Haemost, 82 , pp. Oosting, R. Derksen, L.

Blokzijl, J. Sixma, P. Antiphospholipid antibody positive sera enhance endothelial cell procoagulant activity: studies in a thrombosis model. Thromb Haemost, 68 , pp. Branch, G. Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome:a possible mechanism of thrombosis.

Am J Obstet Gynecol, , pp. Meroni, E. Raschi, M. Camera, C. Testoni, F. Nicoletti, A. Tincani, et al. Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome. J Autoimmun, 15 , pp. Pierangeli, M. Colden-Stanfield, X. Liu, J. Barker, G. Anderson, E.

Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation, 99 , pp. Salmon, G. Girardi, M. Complement activation as a mediator of antiphospholipid antibodies induced pregnancy loss and thrombosis.

Ann Rheum Dis, 61 , pp. Pierangeli, R. Espinola, X. Liu, E. Thrombogenic effects of antiphospholipids antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1 and P-selectin. Circ Res, 88 , pp. Girardi, J. Berman, P. Redecha, L. Spruce, J.

Thruman, D. Kraus, et al. Complement C5a receptors and neutrophils mediate fetal injury in the Antiphospholipid syndrome. J Clin Invest, , pp. Pierangeli, G. Vega-Ostertag, X. Liu, R. Espinola, J. Antiphospholipid syndrome and pregnancy.

Antiphospholipid syndrome. Lupus Foundation of America. Movva, S. Antiphospholipid syndrome workup. Moake, J. Antiphospholipid antibody syndrome. Merck Manual Professional Version. Antiphospholipid syndrome — APS. The Johns Hopkins Lupus Center. Fraser, M.